期刊文献+

淋巴结清扫数目对淋巴结转移阴性SiewertⅡ型食管胃交界部癌的影响 被引量:2

Survival analysis the impact of the number of negative lymph nodes negative lymph node in Siewert Ⅱ adenocarcinoma of the esophagogastrci junction without lymphatic metastasis
下载PDF
导出
摘要 目的:无淋巴结转移的SiewertⅡ型食管胃交界部癌的淋巴结清扫数目对患者预后的影响。方法:选取食管胃交界部癌根治术患者224例。对年龄、性别、肿瘤直径、肿瘤浸润深度、肿瘤分化程度、淋巴结清扫数目等因素做单因素及多因素回归分析,分析淋巴结清扫数目与患者生存率关系。结果:对各因素运用Cox回归模型分析,肿瘤分化程度和淋巴结清扫数目有统计学差异(P<0.05)。相同分化程度患者生存率随淋巴结清扫数目的增加而升高,差异有统计学意义(P<0.05)。结论:应在术中尽可能的提高淋巴结的清扫个数,从而提高患者远期生存率。 Objective To investigate the correlation between the number of resected lymph nodes and the prognosis of patients with node-negative Siewert Type II AEG. Methods Siewert Type II AEG were retrospectively assessed. The prognostic impact of the number of negative LNs and the clinic pathologic factors were analyzed. Results The same degree of the survival rate of the patients were increases with lymph nodes, the difference was statistically significant (P 〈 0.05). Conclusion Clinicians should improve the number of lymph node dissection in the operation.
出处 《实用医学杂志》 CAS 北大核心 2016年第23期3878-3881,共4页 The Journal of Practical Medicine
基金 河南省教育厅自然科学研究计划项目(编号:2011A320013)
关键词 食管胃交界腺癌 淋巴结清扫 生存率 Adenocarcinoma of the esophagogastrci junction Lymph nodes Survival rate
  • 相关文献

参考文献5

二级参考文献77

  • 1邵钦树,陈学荣,邹寿椿.贲门癌的生物学行为及其在外科治疗中的意义[J].中华外科杂志,2003,41(10):738-740. 被引量:28
  • 2Le Chevalier T. Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going[J]? Ann Oncol, 2010, 21(Suppl 7): 196-198.
  • 3Groome P A, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours[J].J Thorac Oncol, 2007, 2(8):694-705.
  • 4Huang CM, Lin]X, Zheng CH, et al. Effect of negative lymph node count on survival for gastric cancer after curative distal gastrecromy[J]. Eur J Surg Oncol, 2011, 37(6):481-487.
  • 5Hsu PK, Huang CS, Wang BY, et al. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection[J]. Ann Thorac Surg, 2013, 96(3) :995-1001.
  • 6Takenaka T, Katsura M, Shikada Y, et al. Outcome of surgical resection as a first line therapy in T3 non-small cell lung cancer patients[J]. World J Surg, 2013, 37(11):2574-2580.
  • 7Donington], Ferguson M, Mazzone P, et al. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer[j]. Chest, 2012,142(6):1620-1635.
  • 8Cerfolio R], Bryant AS, Minnich DJ. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer[J], Ann Thorae Surg, 2012, 94(3):902-906.
  • 9Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer[J].J Clin Oncol, 2003, 21(6):1029-1034.
  • 10Wu YC, Lin CF, Hsu WH, et al. Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control[J], Eur J Cardiothorac Surg, 2003, 24(6):994-1001.

共引文献27

同被引文献6

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部